Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06423950 · ClinicalTrials.gov registry record

Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)

A clinical trial of Pediatric Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

Recruiting
Registry status
35
Enrollment target
1
Study location

NCT06423950 is a study of Pediatric Cancer that is actively recruiting participants, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 35 participants, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06423950, a study of Pediatric Cancer, is actively recruiting participants, sponsored by H. Lee Moffitt Cancer Center and Research Institute.

RECRUITING
Registry status
35 participants
Enrollment target
1
Study location

Study Summary

To evaluate the ability of a multidisciplinary and multisite group, the Pediatric Evolutionary Tumor Board (pedsETB), to develop additional therapeutic strategies in patients without curative options or with suboptimal outcomes.

Conditions Studied

Pediatric Cancer

Interventions

  • OTHER Peds Evolutionary Tumor Board (pedsETB)

Study Locations (1)

Florida

  • Moffitt Cancer Center - Tampa

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2024-05-01
Est. Completion 2027-04

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

502 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06423950

The ClinicalTrials.gov registry entry for NCT06423950 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,490-participant average among 51 other Pediatric Cancer trials with a reported enrollment target (98% lower). The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pediatric Cancer appearing as the primary indexed condition, and to 1 intervention - of which Peds Evolutionary Tumor Board (pedsETB) is the first listed.

NCT06423950 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06423950 about?

NCT06423950 is a clinical study titled "Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)". To evaluate the ability of a multidisciplinary and multisite group, the Pediatric Evolutionary Tumor Board (pedsETB), to develop additional therapeutic strategies in patients without curative options or with suboptimal outcomes.

What is the current status of trial NCT06423950?

This trial is currently recruiting. The enrollment target is 35 participants. The study started on 2024-05-01. Estimated completion is 2027-04.

What conditions does trial NCT06423950 study?

This clinical trial studies the following conditions: Pediatric Cancer.

What interventions are being tested in trial NCT06423950?

The interventions under investigation include: Peds Evolutionary Tumor Board (pedsETB) (OTHER).

Who is sponsoring clinical trial NCT06423950?

This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06423950 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pediatric Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pediatric Cancer

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.